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P503 Agreement between disc diffusion and E-test
methods to assess the carbapenem susceptibility of four
Gram-negative nosocomial pathogens
P. Zarakolu, B. Cakir, S. Unal, O. Uzun
Ankara, TR
Objectives: The aim of this study was to assess the carbape-
nem susceptibility of four nosocomial pathogens and to
evaluate the reliability of the susceptibility results deter-
mined by E-test and disc diffusion (DD) methods.
Methods: Escherichia coli (n ¼ 73), Klebsiella pneumoniae
(n ¼ 60), Pseudomonas aeruginosa (n ¼ 70) and Acinetobacter
spp. (n ¼ 70) isolated from nosocomial infections in 2002–
2003 were included in the study. Thirty-ﬁve per cent of the
strains were isolated from intensive care units. After deter-
mining antimicrobial susceptibility against imipenem and
meropenem by DD (10 lg; Oxoid, UK) and Etest (AB Bio-
disk, Solna, Sweden) methods, the results were categorised
as susceptible (S), intermediate (I) and resistant (R) according
to the NCCLS criteria. For statistical analyses, the
intermediate group was included in the resistant category
because of the low numbers of bacteria in the former group.
Results: None of E. coli or K. pneumoniae strains were resist-
ant to carbapenems, whereas, resistance reached up to 59.0%
in Acinetobacter spp. and P. aeruginosa isolates. By either
method, the pattern of the susceptibility of the four bacteria
was not statistically signiﬁcantly different for imipenem vs.
meropenem. Total agreement of DD and E-test methods for
susceptibility to imipenem was 95.7%, and 90.0% in Acine-
tobacter spp. and P. aeruginosa, respectively; and susceptibility
to meropenem was 90.0% for both bacteria. However, the
difference of the results obtained by either method was sta-
tistically signiﬁcant for Acinetobacter spp.
Conclusion: Study results suggest a high resistance rate for
Acinetobacter spp. and P. aeruginosa strains against carbape-
nem antibiotics in our hospital. Further studies are needed to
clarify whether E-test should be used to conﬁrm meropenem
resistance of Acinetobacter spp. determined by DD method.
P594 Intracellular killing of drug-resistant
Staphylococcus aureus by different antibiotics
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Objectives: The emergence of epidemic multiple resistant
Staphylococcus aureus (EMRSA) and vancomycin intermedi-
ate susceptible (VISA) strains has heightened concerns
about the treatment of associated infections. It has also
been suggested that intracellular survival of S. aureus in
phagocytic cells play an important role in the pathogenesis
of associated infections, moreover it may contribute to fail-
ure of antimicrobial chemotherapy. Therefore intracellularly
active antibiotics may be of value in treatment. This study
was aimed to investigate the effect of linezolid, moxiﬂoxa-
cin and vancomycin on the intracellular survival of S. aure-
us.
Methods: Two clinical isolates of methicillin resistant S. au-
reus (EMRSA 16 also resistant to macrolids and VISA
3759.v with intermediate susceptibility to vancomycin) were
tested in J774 macrophage cell line. Susceptibility of the
strains was determined by NCCLS broth microdilution
method. Cells were infected with bacteria opsonised with
10% normal pooled human serum in Hank s balanced salt
solution supplemented with 1% gelatine. After 2 h of incu-
bation the supernatant was discarded and cells were
washed three times in the buffer. Thereafter, antibiotics
were added to the cells at the following concentration:
0  MIC, 1/2  MIC, 1  MIC, 2  MIC in triplicate. Sam-
ples were taken 1, 2, 3, 4 h after antibiotic addition. Cells
were washed three times with phosphate buffered saline,
then lysed with distilled water. Bacterial count of the cell
lysate was determined by the microdilution followed by
blood agar plating. Each test was performed three times.
Results: In the presence of vancomycin, intracellular killing
was not enhanced, as linezolid and moxiﬂoxacin facilitated
the clearance of live intracellular bacteria even at sub-MIC
concentrations.
Discussion: Whether this enhancement is due to inhibition of
intracellular bacterial multiplication, or due to an effect on
the host cells’ killing mechanisms, or both remains to be
seen. According to our observation linezolid and moxiﬂoxa-
cin have been shown bioactive intracellularly against MRSA.
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Table 1. Susceptibility of Acinetobacter spp and P. aeruginosa strains to imipenem
and meropenem by comparing results of DF and Etest Methods
DD method
Etest method
R/I S McNemar test p-value
Imipenem
Acientobacter spp R/I 37 3 0.250
S 0 30
P. aeruginosa R/I 34 4 1.000
S 3 29
Meropenem
Acinetobacter spp R/I 32 9 0.021
S 1 28
P. aeruginosa R/I 30 7 0.344
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